128 related articles for article (PubMed ID: 6314043)
1. Cannabinoid concentrations in plasma after passive inhalation of marijuana smoke.
Mason AP; Perez-Reyes M; McBay AJ; Foltz RL
J Anal Toxicol; 1983; 7(4):172-4. PubMed ID: 6314043
[TBL] [Abstract][Full Text] [Related]
2. Passive cannabis smoke exposure and oral fluid testing.
Niedbala S; Kardos K; Salamone S; Fritch D; Bronsgeest M; Cone EJ
J Anal Toxicol; 2004 Oct; 28(7):546-52. PubMed ID: 15516313
[TBL] [Abstract][Full Text] [Related]
3. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ
J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389
[TBL] [Abstract][Full Text] [Related]
4. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.
Huestis MA; Cone EJ
J Anal Toxicol; 2004 Sep; 28(6):394-9. PubMed ID: 15516285
[TBL] [Abstract][Full Text] [Related]
5. Concentrations of delta9-tetrahydrocannabinol and 11-nor-9-carboxytetrahydrocannabinol in blood and urine after passive exposure to Cannabis smoke in a coffee shop.
Röhrich J; Schimmel I; Zörntlein S; Becker J; Drobnik S; Kaufmann T; Kuntz V; Urban R
J Anal Toxicol; 2010 May; 34(4):196-203. PubMed ID: 20465865
[TBL] [Abstract][Full Text] [Related]
6. Passive inhalation of marijuana smoke: urinalysis and room air levels of delta-9-tetrahydrocannabinol.
Cone EJ; Johnson RE; Darwin WD; Yousefnejad D; Mell LD; Paul BD; Mitchell J
J Anal Toxicol; 1987; 11(3):89-96. PubMed ID: 3037193
[TBL] [Abstract][Full Text] [Related]
7. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH).
Huestis MA; Henningfield JE; Cone EJ
J Anal Toxicol; 1992; 16(5):283-90. PubMed ID: 1338216
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids in blood and urine after passive inhalation of Cannabis smoke.
Mørland J; Bugge A; Skuterud B; Steen A; Wethe GH; Kjeldsen T
J Forensic Sci; 1985 Oct; 30(4):997-1002. PubMed ID: 2999292
[TBL] [Abstract][Full Text] [Related]
9. Passive inhalation of marihuana smoke and urinary excretion of cannabinoids.
Perez-Reyes M; Di Guiseppi S; Mason AP; Davis KH
Clin Pharmacol Ther; 1983 Jul; 34(1):36-41. PubMed ID: 6305545
[TBL] [Abstract][Full Text] [Related]
10. Driving Under the Influence of Marijuana Versus Driving and Dying Under the Influence of Marijuana: A Comparison of Blood Concentrations of Δ9-Tetrahydrocannabinol, 11-Hydroxy-Δ9-Tetrahydrocannabinol, 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol and Other Cannabinoids in Arrested Drivers Versus Deceased Drivers.
Lemos NP; San Nicolas AC; Volk JA; Ingle EA; Williams CM
J Anal Toxicol; 2015 Oct; 39(8):588-601. PubMed ID: 26378132
[TBL] [Abstract][Full Text] [Related]
11. Passive inhalation of cannabis smoke.
Law B; Mason PA; Moffat AC; King LJ; Marks V
J Pharm Pharmacol; 1984 Sep; 36(9):578-81. PubMed ID: 6149279
[TBL] [Abstract][Full Text] [Related]
12. Nonsmoker Exposure to Secondhand Cannabis Smoke. III. Oral Fluid and Blood Drug Concentrations and Corresponding Subjective Effects.
Cone EJ; Bigelow GE; Herrmann ES; Mitchell JM; LoDico C; Flegel R; Vandrey R
J Anal Toxicol; 2015 Sep; 39(7):497-509. PubMed ID: 26139312
[TBL] [Abstract][Full Text] [Related]
13. Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke.
Cone EJ; Johnson RE
Clin Pharmacol Ther; 1986 Sep; 40(3):247-56. PubMed ID: 3017628
[TBL] [Abstract][Full Text] [Related]
14. Analysis of forensic specimens for cannabinoids. II. Relationship between blood delta 9-tetrahydrocannabinol and blood and urine 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid concentrations.
Moody DE; Monti KM; Crouch DJ
J Anal Toxicol; 1992; 16(5):302-6. PubMed ID: 1338218
[TBL] [Abstract][Full Text] [Related]
15. Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration.
Lee D; Vandrey R; Milman G; Bergamaschi M; Mendu DR; Murray JA; Barnes AJ; Huestis MA
Anal Bioanal Chem; 2013 Sep; 405(23):7269-79. PubMed ID: 23831756
[TBL] [Abstract][Full Text] [Related]
16. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.
Huestis MA; Henningfield JE; Cone EJ
J Anal Toxicol; 1992; 16(5):276-82. PubMed ID: 1338215
[TBL] [Abstract][Full Text] [Related]
17. Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol.
Hartman RL; Brown TL; Milavetz G; Spurgin A; Gorelick DA; Gaffney G; Huestis MA
Clin Chem; 2015 Jun; 61(6):850-69. PubMed ID: 26019183
[TBL] [Abstract][Full Text] [Related]
18. GC/MS and EMIT analyses for delta 9-tetrahydrocannabinol metabolites in plasma and urine of human subjects.
McBurney LJ; Bobbie BA; Sepp LA
J Anal Toxicol; 1986; 10(2):56-64. PubMed ID: 3009969
[TBL] [Abstract][Full Text] [Related]
19. Screening for cannabinoids in blood using EMIT: concentrations of delta-9-tetrahydrocannabinol in relation to EMIT results.
Gjerde H
Forensic Sci Int; 1991; 50(1):121-4. PubMed ID: 1657743
[TBL] [Abstract][Full Text] [Related]
20. Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography-Tandem Mass Spectrometry.
Andrenyak DM; Moody DE; Slawson MH; O'Leary DS; Haney M
J Anal Toxicol; 2017 May; 41(4):277-288. PubMed ID: 28069869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
